Developmental Medicine and Child Neurology
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: An open‐label study extension of the SALIVA trial
Publication type: Journal Article
Publication date: 2025-02-09
scimago Q1
SJR: 1.251
CiteScore: 7.8
Impact factor: 3.8
ISSN: 00121622, 14698749
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.